Other current assets consisted of the following (in thousands):
June 30,
December 31,
2025
2024
Research and development credits receivable
$
18,277
12,929
Prepayments
8,232
10,033
Clinical materials
—
59
VAT receivable
1,305
1,599
Other current assets
3,516
3,170
31,330
27,790
No definition available.
Tabular disclosure of the carrying amounts of other current assets.